Who is sponsoring NCT01819805?

NCT01819805 is sponsored by Janssen Korea, Ltd., Korea.

What condition does NCT01819805 study?

NCT01819805 studies Chronic Pain.

What drugs are being tested in NCT01819805?

Interventions: No intervention.

What is the status of NCT01819805?

NCT01819805 is currently COMPLETED.

Last reviewed 2014-12-31 · How we verify

Evaluation of the Improvement of Pain and Health-Related Quality of Life in Patients With Chronic Non-Malignant Pain Taking Tramadol HCl (75mg)/Acetaminophen (650mg) Extended Release Tablet: Multicenter, Open Label, Prospective, Observational Study

NCT01819805 COMPLETED

The purpose of this study is to evaluate the impact of extended release tramadol hydrochloride (75 mg) and acetaminophen (650 mg) tablets on improvement of pain.

Details

Lead sponsor	Janssen Korea, Ltd., Korea
Status	COMPLETED
Enrolment	1065
Start date	2011-09
Completion	2012-07

Conditions

Chronic Pain

Interventions

No intervention

Primary outcomes

Number of patients with more than 30 percentage reduction in percentage Pain Intensity Difference (PID) from baseline — Baseline (Week 1) to Week 12
Numerical Rating Scale (NRS) is an 11-point scale to measure the pain intensity and is used by patients to rate their pain from 0 (absence of pain) to 10 (extreme pain). Percentage PID =\[(NRS score at baseline - NRS score at Week 12)/NRS score at baseline\] X 100.

Countries

South Korea